Article info
Spinal cord injury
Research paper
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
- Correspondence to Dr Jens Kuhle, Blizard Institute, Barts and the London School of Medicine and Dentistry, 4 Newark Street, Queen Mary University of London, London, UK; j.kuhle{at}qmul.ac.uk
Citation
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
Publication history
- Received December 13, 2013
- Revised April 23, 2014
- Accepted May 19, 2014
- First published June 16, 2014.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions